EN DE

Truking Technology Limited (300358) Fair Value & Analysis

Healthcare · CN · Market cap 5.8B CNY

TT Truking Technology Limited 300358 · SHE
Price¥9.20
Fair Value¥6.66
Upside-27.7%
Quality42/100
Watch Truking Technology Limited for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 5.7% net margin
Low debt · generates free cash flow
Ranks above peers (8/13)
Narrow moat 35/100
Evidence: High Range ¥5.02 – ¥8.32 Share as image

Fair value as of: Jul 9, 2026

From 26 valuation models · updated 32 days ago

Share price +12.7% over the past month.

Below-average quality, and screening another 28% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥8.32). The favourable scenario is already priced in.
  • Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥27.75 ¥5.80 Fair Value ¥6.66 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.

How to read this chart

60‑month range ¥5.80 – ¥27.75 · fair‑value band ¥5.02 – ¥8.32 · the ¥9.20 price screens above the ¥6.66 fair value. Dashed = 300-day average. As of Jul 9, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Truking Technology Limited (300358) currently trades at ¥9.20, while our model-based Fair Value estimate is ¥6.66, implying the stock looks roughly 27.7% overvalued today. The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Truking Technology Limited generated revenue of 5.8B CNY at a net margin of 5.7%. Revenue grew 2.4% year over year. It earns a return on equity of 6.6%. Net debt stands at 927M CNY. Fundamentals as of Jul 9, 2026

Our scenario range runs from ¥5.02 (bear case) to ¥8.32 (bull case); at ¥9.20, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 29% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -28%, 300358 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥10.87 ¥19.96 ¥35.54 80
Residual Income ¥5.77 ¥5.73 ¥5.22 76
Rev-Margin DCF ¥8.25 ¥13.63 ¥21.35 74
All 26 models by family
DCF Models
FCF DCF ¥11.23 ¥18.35 ¥36.66 38
Owner Earnings ¥6.69 ¥12.24 ¥22.92 31
5Y Revenue Exit ¥8.25 ¥13.61 ¥21.78 39
5Y EBITDA Exit ¥11.42 ¥20.70 ¥34.12 41
5Y P/E Exit ¥8.44 ¥14.25 ¥21.36 38
10Y Revenue Exit ¥8.95 ¥14.83 ¥23.48 36
10Y EBITDA Exit ¥11.29 ¥20.34 ¥35.99 37
10Y P/E Exit ¥9.27 ¥15.15 ¥24.44 35
Earnings-Based
Graham-Dodd ¥2.42 ¥15.36 ¥21.47 54
Lynch FV ¥4.44 ¥6.34 ¥8.24 50
PEG = 1.0 ¥4.44 ¥6.34 ¥8.24 46
EPV ¥6.28 ¥7.03 ¥7.67 59
Dividend Discount
Gordon GGM ¥0.6100 ¥1.21 ¥1.84 70
DDM Multi-Stage ¥0.6100 ¥1.05 ¥1.28 61
Multiples
P/E Multiple ¥5.88 ¥7.83 ¥9.79 63
P/S Multiple ¥4.54 ¥6.05 ¥7.57 58
P/B Multiple ¥4.54 ¥6.05 ¥7.57 55
EV/EBIT ¥8.91 ¥11.35 ¥13.79 53
EV/EBITDA ¥11.93 ¥15.39 ¥18.84 54
EV/Revenue ¥6.81 ¥9.05 ¥11.29 43
Asset-Based
NCAV (Graham) ¥3.88 ¥5.20 ¥7.76 50
Growth DCF
Growth DCF ¥10.87 ¥19.96 ¥35.54 80
Rev-Margin DCF ¥8.25 ¥13.63 ¥21.35 74
Economic Profit
Residual Income ¥5.77 ¥5.73 ¥5.22 76
ROIC Compounder ¥6.28 ¥7.03 ¥7.67 72
Growth Earnings
Growth-Adj P/E ¥6.44 ¥9.20 ¥11.96 68

Widest divergence: DCF Models (¥14.83) versus Dividend Discount (¥1.05). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 5.8B CNY
Revenue growth (YoY) +2.4%
Net margin 5.7%
Return on equity 6.6%
Free cash flow 489M CNY FY2025
P/E ratio 15.1
More key figures
Operating margin 6.2%
EPS (TTM) ¥0.5400
EPS growth (YoY) -86.5%
Net debt 927M CNY FY2024

Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 42/100

Of which business quality 43 · Market factors (momentum, volatility) 40

Profitability 27
Margins and returns on capital today
Quality Growth 53
Are margins and returns improving?
Cashflow 61
Earnings quality: real cash, not paper profit
Fin. Strength 48
Balance sheet, leverage, solvency risk
Investment 68
Disciplined investing over empire-building
Low Volatility 59
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 41
Distance to the 52-week high (market factor)
Net Issuance 5
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Truking Technology Limited engages in medical equipment business in China and internationally. It is involved in the pharmaceutical water business that includes pharmaceutical water preparation, storage and distribution systems, process tank groups, public works, and sewage treatment; biological engineering such as biological reaction systems, liquid …

Full company description

Truking Technology Limited engages in medical equipment business in China and internationally. It is involved in the pharmaceutical water business that includes pharmaceutical water preparation, storage and distribution systems, process tank groups, public works, and sewage treatment; biological engineering such as biological reaction systems, liquid preparation systems, separation and purification systems, filtration systems, disposable reaction systems, and biologically related consumables; sterile preparations that include aseptic filling systems, powder filling systems, freeze-dryer feeding and discharging systems, pre-filling systems, isolation systems, and special dispensing systems; and solid preparations such as fluidization, granulation, tablet compression, coating, capsules, and aluminum-plastic packaging. The company also engages in post-inspection packaging, which includes lighting inspection, inspection systems, intelligent post-package systems, and logistics and warehousing systems, as well as Chinese medicine preparations such as extraction, concentration, drying, purification and separation, reaction, and crystallization. It additionally provides AI and informatization systems; EPCMV services that include design and consulting, information construction, and verification services; cell and gene therapy solutions such as fully automatic intelligent cell-culture equipment and process consumables; and purification engineering and related services. Truking Technology Limited was founded in 2000 and is headquartered in Changsha, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Truking Technology Limited reported revenue of ¥5.8B in FY2025 versus ¥5.3B in FY2021, a compound +2.3%/yr. Reported net income was ¥255M in FY2025, compounding −18.1%/yr from FY2021.

Growth Quality 75/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
5.8B CNY
Latest YoY
−1.1%
Avg. growth/yr (3Y)
−3.7%
Avg. growth/yr (5Y)
+10.0%
Avg. growth/yr (17Y)
+24.5%
Revenue +2.3%/yr
FY21 ¥5.3B
FY22 ¥6.4B
FY23 ¥6.9B
FY24 ¥5.8B
FY25 ¥5.8B
Net income −18.1%/yr
FY21 ¥566M
FY22 ¥567M
FY23 ¥317M
FY24 −¥453M
FY25 ¥255M

300358 screens 28% overvalued. Compare with Intuitive Surgical, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Truking Technology Limited Fair Value". https://www.fairvalue-calculator.com/stock/300358

Peer Group

Medical Instruments & Supplies · 203 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 42 · Bottom 25%
Fair Value upside −28% · Above median
Return on equity (TTM) 7% · Above median
Return on assets 1% · Below median
Net margin (TTM) 6% · Below median
Operating margin (TTM) 6% · Below median
Revenue growth 2% · Below median
Debt / equity 0.07× · Lower than median

Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper

P/E (TTM) 15.1× · Cheaper than 75% of peers
P/B 1.05× · Cheaper than 75% of peers
P/S (TTM) 1.01× · Cheaper than 75% of peers
P/FCF 1.8× · Cheaper than median
EV/EBITDA 8.8× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 12 · sector 27
PAST 26 · sector 25
HEALTH 97 · sector 96
DIVIDEND 0 · sector 32

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.33 $150.04 -63%
EssilorLuxottica Société anonyme 1EL €172.45 €68.55 -60%
Medline Inc MDLN $41.11 $30.15 -27%
Becton, Dickinson and Company BDX $150.65 $103.53 -31%
Alcon Inc ALC $70.26 $39.78 -43%
ResMed Inc RMD $203.87 $187.89 -8%
West Pharmaceutical Services, Inc WST $353.71 $143.97 -59%
Straumann Holding STMN CHF 106.00 CHF 47.31 -55%
Sartorius Stedim Biotech S.A DIM €188.50 €51.16 -73%
Coloplast A/S COLOB kr 414.00 kr 382.22 -8%

Compare Truking Technology Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Truking Technology Limited (300358) overvalued or undervalued?
As of Jul 9, 2026, our model estimates a fair value of ¥6.66 versus a price of ¥9.20, about −28% (overvalued).
What is the fair value of 300358?
Our model-based fair value for Truking Technology Limited is ¥6.66 (as of Jul 9, 2026), built from audited fundamentals. The current price is ¥9.20.
What is the quality score of 300358?
Truking Technology Limited has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Truking Technology Limited (300358)?
Truking Technology Limited reported trailing-twelve-month revenue of about 5.8B CNY (latest available figure, as of Jul 9, 2026).
What is the net profit margin of 300358?
The net profit margin of Truking Technology Limited is about 5.7%, meaning it keeps roughly 5.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Truking Technology Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.